Information Journal Paper
APA:
Copy. (2017). Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence. Toxicology and applied pharmacology, 335(-), 56-63. SID. https://sid.ir/paper/737008/en
Vancouver:
Copy. Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence. Toxicology and applied pharmacology[Internet]. 2017;335(-):56-63. Available from: https://sid.ir/paper/737008/en
IEEE:
Copy, “Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence,” Toxicology and applied pharmacology, vol. 335, no. -, pp. 56–63, 2017, [Online]. Available: https://sid.ir/paper/737008/en